AGN 193109 is a high affinity pan-retinoic acid receptor (RAR) antagonist with Kds of 2, 2 and 3 nM at RARα, RARβ and RARγ, respectively.

Magnolol is a multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis, with antifungal, antibacterial and antioxidant effects, as well as anti-inflammatory activity by interferring with NF-κB signaling and inhibiting IL-6-induced STAT3 activation.

AC55649 is an agonist of the retinoic acid receptor β (RAR-β).

HX 531 is a potent RXR antagonist with IC50 of 18 nM.

LG-100064 is an agonist of RXRα, RXRβ and RXRγ with EC50s of 330 nM, 200 nM, and 260 nM, respectively.

(R)-Flurbiprofen is the R-enantiomer of the racemate NSAID flurbiprofen, inhibiting the binding of [3H]9-cis-RA to RXRαLBD with IC50 of 75 μM.

Tazarotene selectively binds to retinoic acid receptors RAR-β and RAR-γ, it is the first receptor-selective aromatic retinoid that has effective treatment for psoriasis, hemorrhoids.

Tamibarotene is an agonist of retinoic acid receptor α (RARα) with ED50 of 0.79 nM that can induce differentiation and apoptosis of HL-60 cells.

TTNPB is an agonist of RAR and can inhibit binding of [3H]tRA with RARα (IC50 = 5.1 nM), RARβ (IC50 = 4.5 nM), and RARγ (IC50 = 9.3 nM).

CD437 is a selective Retinoic Acid Receptor γ (RARγ) agonist.

WYC-209 is a RAR agonist which induces apoptosis primarily via the caspase 3 pathway.

LE 135 is a selective RARβ antagonist with Ki of 0.22 μM.

Acitretin is an analog of retinoid that can activate α-secretase ADAM10 gene expression. It has been used in the treatment of severe psoriasis.